Total Payments
$4,054
2024 Payments
$781.55
Companies
22
Transactions
129
Medicare Patients
2,292
Medicare Billing
$390,179
Payment Breakdown by Category
Food & Beverage$3,787 (93.4%)
Education$267.10 (6.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,787 | 122 | 93.4% |
| Education | $267.10 | 7 | 6.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $824.31 | 31 | $0 (2024) |
| Celgene Corporation | $822.52 | 42 | $0 (2019) |
| ABBVIE INC. | $794.69 | 20 | $0 (2024) |
| Amgen Inc. | $232.67 | 9 | $0 (2024) |
| Janssen Biotech, Inc. | $206.69 | 4 | $0 (2024) |
| Lilly USA, LLC | $141.50 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $124.71 | 1 | $0 (2024) |
| Genentech USA, Inc. | $124.07 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $123.37 | 1 | $0 (2019) |
| GENZYME CORPORATION | $109.48 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $781.55 | 27 | ABBVIE INC. ($287.93) |
| 2023 | $611.34 | 24 | ABBVIE INC. ($197.33) |
| 2022 | $171.74 | 4 | PFIZER INC. ($76.12) |
| 2021 | $98.43 | 1 | AbbVie Inc. ($98.43) |
| 2019 | $1,034 | 17 | Celgene Corporation ($152.38) |
| 2018 | $660.27 | 27 | Celgene Corporation ($266.57) |
| 2017 | $696.70 | 29 | Celgene Corporation ($403.57) |
All Payment Transactions
129 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | SCILEX PHARMACEUTICALS INC. | GLOPERBA (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Analgesic | ||||||
| 11/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $124.71 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $120.61 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Bone Health | ||||||
| 09/19/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $25.10 | General |
| Category: Immunology | ||||||
| 09/17/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/12/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Inflammation | ||||||
| 08/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: IMMUNOLOGY | ||||||
| 06/20/2024 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: Biosimilars | ||||||
| 06/18/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: Immunology | ||||||
| 06/13/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/23/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $22.04 | General |
| Category: Immunology | ||||||
| 05/16/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/09/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Inflammation | ||||||
| 05/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.61 | General |
| Category: IMMUNOLOGY | ||||||
| 04/25/2024 | ABBVIE INC. | RINVOQ (Biological), HUMIRA | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: IMMUNOLOGY | ||||||
| 04/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: IMMUNOLOGY | ||||||
| 03/14/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Food and Beverage | In-kind items and services | $71.77 | General |
| Category: Immunology | ||||||
| 03/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: IMMUNOLOGY | ||||||
| 01/25/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $15.85 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 703 | 3,554 | $261,859 | $111,764 |
| 2022 | 9 | 517 | 3,213 | $253,106 | $107,989 |
| 2021 | 9 | 492 | 2,683 | $209,349 | $93,868 |
| 2020 | 11 | 580 | 2,112 | $195,853 | $76,558 |
Total Patients
2,292
Total Services
11,562
Medicare Billing
$390,179
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 28 | 2,400 | $69,600 | $40,956 | 58.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 225 | 449 | $116,291 | $40,144 | 34.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 53 | 72 | $26,242 | $9,318 | 35.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 23 | 23 | $8,339 | $6,502 | 78.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 90 | $16,020 | $6,239 | 38.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $11,968 | $4,167 | 34.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 182 | 300 | $6,600 | $2,486 | 37.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 24 | 24 | $1,044 | $775.68 | 74.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 11 | $2,472 | $581.39 | 23.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 33 | 47 | $2,867 | $513.04 | 17.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 23 | 104 | $416.00 | $81.83 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 235 | 511 | $120,085 | $46,504 | 38.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 22 | 2,220 | $64,380 | $37,185 | 57.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 53 | 70 | $23,240 | $8,975 | 38.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 47 | 47 | $16,544 | $5,866 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 93 | $14,973 | $5,739 | 38.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 20 | 27 | $5,974 | $1,555 | 26.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $4,266 | $1,461 | 34.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 27 | 48 | $2,928 | $542.82 | 18.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 29 | 179 | $716.00 | $162.09 | 22.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 246 | 464 | $103,936 | $43,874 | 42.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 20 | 1,800 | $52,200 | $29,760 | 57.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 71 | 95 | $14,535 | $6,308 | 43.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 44 | 44 | $15,004 | $5,688 | 37.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 31 | 38 | $12,008 | $5,172 | 43.1% |
About Dr. Sunil John, MD
Dr. Sunil John, MD is a Rheumatology healthcare provider based in Orland Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427154665.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sunil John, MD has received a total of $4,054 in payments from pharmaceutical and medical device companies, with $781.55 received in 2024. These payments were reported across 129 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,787).
As a Medicare-enrolled provider, John has provided services to 2,292 Medicare beneficiaries, totaling 11,562 services with total Medicare billing of $390,179. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Other Specialties Rheumatology
- Location Orland Park, IL
- Active Since 09/15/2006
- Last Updated 03/25/2025
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1427154665
Products in Payments
- XELJANZ (Drug) $808.21
- Otezla (Drug) $426.70
- RINVOQ (Biological) $387.05
- KEVZARA (Drug) $208.48
- SKYRIZI (Biological) $196.64
- TREMFYA (Drug) $134.92
- COSENTYX (Drug) $124.71
- Actemra (Biological) $124.07
- OLUMIANT (Drug) $111.35
- Cimzia (Drug) $108.36
- Humira (Biological) $100.12
- STELARA (Biological) $92.24
- ORENCIA (Biological) $81.75
- SIMPONI ARIA (Biological) $71.77
- KRYSTEXXA (Biological) $70.27
- TAVNEOS (Drug) $54.93
- Enbrel (Biological) $46.61
- TALTZ (Drug) $29.15
- YUFLYMA (Biological) $26.75
- IDACIO (Biological) $25.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Orland Park
Dr. Cory Conniff, Md, MD
Rheumatology — Payments: $19,374
Rheumatology $19,374
Dr. Fariha Kausar, Md, MD
Rheumatology — Payments: $8,622
Rheumatology $8,622
Dr. Olga Vila-Sola, Md, MD
Rheumatology — Payments: $5,846
Rheumatology $5,846
Dr. Claudia Vergara, M.d, M.D
Rheumatology — Payments: $4,331
Rheumatology $4,331
Laisvyde Smajkic, Md, MD
Rheumatology — Payments: $364.59
Rheumatology $364.59